Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report)'s stock price reached a new 52-week high on Thursday . The company traded as high as $41.84 and last traded at $41.77, with a volume of 22209 shares. The stock had previously closed at $41.61.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on OHI shares. Scotiabank upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. Truist Financial increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research note on Wednesday, September 4th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a "buy" rating and a $45.00 target price for the company. BMO Capital Markets increased their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a research report on Monday, October 7th. Finally, Mizuho cut shares of Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and lifted their price objective for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Omega Healthcare Investors has a consensus rating of "Hold" and a consensus target price of $37.80.
Get Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Stock Up 0.3 %
The stock has a market cap of $10.31 billion, a PE ratio of 37.59, a P/E/G ratio of 1.34 and a beta of 1.00. The business has a 50 day moving average of $39.93 and a 200-day moving average of $35.47. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The company had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business's revenue was up 17.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.74 EPS. Equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.
Institutional Investors Weigh In On Omega Healthcare Investors
A number of institutional investors have recently added to or reduced their stakes in OHI. Vanguard Group Inc. raised its stake in shares of Omega Healthcare Investors by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock valued at $1,120,478,000 after acquiring an additional 165,105 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Omega Healthcare Investors by 7.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after buying an additional 272,299 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of Omega Healthcare Investors by 4.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock valued at $110,971,000 after buying an additional 143,521 shares during the period. LSV Asset Management lifted its position in Omega Healthcare Investors by 0.7% during the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust's stock worth $67,411,000 after acquiring an additional 14,000 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its holdings in Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock worth $32,384,000 after acquiring an additional 861,907 shares during the period. Hedge funds and other institutional investors own 65.25% of the company's stock.
About Omega Healthcare Investors
(
Get Free Report)
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Further Reading
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
